SCHEMBL821877

SCHEMBL821877

O=C(CCO)OCCOCCO

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
TSHR P16473 6/20 0.48
MAPK1 P28482 1/20 0.48
EPHX2 P34913 1/20 0.43
DGKA P23743 1/20 0.40
ALDH1A1 P00352 4/20 0.38
TP53 P04637 2/20 0.38
HIF1A Q16665 2/20 0.38
ADRA2A P08913 1/20 0.38
ADRA1A P35348 1/20 0.38
HSD17B10 Q99714 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
MAPT P10636 2/20 0.37
BLM P54132 1/20 0.37
THRB P10828 1/20 0.37
HTT P42858 1/20 0.37
MGLL Q99685 1/20 0.36
APP P05067 1/20 0.35
CYP4F2 P78329 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1815429 0.93 MEN1 (0.55) MEN1KMT2ATSHRMAPK1EPHX2
SCHEMBL21055107 0.93 MEN1 (0.55) MEN1KMT2ATSHRMAPK1EPHX2
SCHEMBL21876951 0.93 MEN1 (0.55) MEN1KMT2ATSHRMAPK1EPHX2
SCHEMBL1986732 0.93 MEN1 (0.55) MEN1KMT2ATSHRMAPK1EPHX2
SCHEMBL10943506 0.91 MEN1 (0.52) MEN1KMT2ATSHRMAPK1EPHX2
SCHEMBL6417620 0.88 DGKA (0.54) MEN1KMT2ATSHRMAPK1EPHX2
SCHEMBL2845276 0.88 MEN1 (0.50) MEN1KMT2ATSHRMAPK1EPHX2
SCHEMBL207583 0.88 DGKA (0.54) MEN1KMT2ATSHRMAPK1EPHX2
SCHEMBL2922616 0.88 DGKA (0.54) MEN1KMT2ATSHRMAPK1EPHX2
SCHEMBL11579370 0.88 DGKA (0.54) MEN1KMT2ATSHRMAPK1EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110287102-A1 CHAIN EXTENDERS POLYNOVO BIOMATERIALS PTY LIMITED (AU) 2011-11-24 US disclosed
US-20110287102-A1 CHAIN EXTENDERS POLYNOVO BIOMATERIALS PTY LIMITED (AU) 2011-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110287102-A1 CHAIN EXTENDERS UMPS, PUF60, SMCHD1 MEN1 1922/4885KMT2A 3905/4885TSHR 4016/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.